|
Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC |
|
|
|
Titel: |
Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC |
Auteur: |
Ou, S.-H. I. Jänne, P.A. Bartlett, C.H. Tang, Y. Kim, D.-W. Otterson, G.A. Crinò, L. Selaru, P. Cohen, D.P. Clark, J.W. Riely, G.J. |
Verschenen in: |
Annals of oncology |
Paginering: |
Jaargang 25 () nr. 2 pagina's 415-422 |
Jaar: |
2014 |
Inhoud: |
|
Uitgever: |
European Society for Medical Oncology |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|